Search Within

Steven M Horwitz

Formats
  1. Meeting Abstract (374)
  2. Journal Article (244)
  3. Review (13)
  4. Guidelines (10)
  5. Research Letter (9)
  6. Book Section (6)
  7. Editorial (4)
  8. Correspondence (3)
  9. Miscellaneous (1)
Groups
  1. Center for Hematologic Malignancies (664)
  2. Department of Medicine (664)
  3. Hematologic Malignancies, Division of (664)
  4. Lymphoma (664)
  5. Population Sciences Research Program (664)
  6. Survivorship Research (170)

More Groups

People
  1. Alison Moskowitz (231)
  2. Andrew Zelenetz (166)
  3. Paul Hamlin (137)
  4. Ariela Noy (136)
  5. David Straus (121)
  6. Maria Palomba (109)

More People

Years
  1. 2025 (12)
  2. 2024 (50)
  3. 2023 (41)
  4. 2022 (34)
  5. 2021 (53)
  6. 2020 (52)

More Years

Publications
  1. Blood (255)
  2. Journal of Clinical Oncology (64)
  3. Hematological Oncology (38)
  4. Annals of Oncology (18)
  5. Blood Advances (18)
  6. Leukemia and Lymphoma (18)

More Publications

Publishers
  1. American Society of Hematology (276)
  2. American Society of Clinical Oncology (65)
  3. Wiley Blackwell (55)
  4. Elsevier Inc. (33)
  5. Oxford University Press (25)
  6. Taylor & Francis Group (22)

More Publishers

Results (664)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Responses to romidepsin by line of therapy in patients with relapsed/refractory (R/R) peripheral T-cell lymphoma (PTCL)
    Meeting Abstract

    Foss, F. M.; Pro, B.; Prince, H. M.; Sokol, L.; Greenwood, M.; Caballero, D.; Horwitz, S. M.; Coiffier, B.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • US Intergroup phase II trial (SWOG 1108) of alisertib, an investigational aurora A kinase (AAK) inhibitor, in patients with peripheral T-cell lymphoma (PTCL; NCT01466881)
    Meeting Abstract

    Barr, P. M.; Li, H. L.; Spier, C. M.; Mahadevan, D.; Friedberg, J. W.; LeBlanc, M. L.; Ul Haq, M.; Flowers, C.; Wagner-Johnston, N. D.; Cheson, B. D.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Commentary
    Journal Article

    Horwitz, S. M.
    Clinical Advances in Hematology & Oncology (2014)

    Fulltext@MSK | Save
  • Subsequent hematopoietic stem cell transplantation in belinostat-treated patients with relapsed/refractory peripheral T-cell lymphoma (R/R PTCL)
    Meeting Abstract

    Shustov, A. R.; Al-Ali, H. K.; Wulf, G.; Hsu, P.; Choi, M. R.; Allen, L. F.; Visser, O. J.; Zachee, P.; Horwitz, S. M.
    Blood (2014)

    Fulltext@MSK | Save
  • A Cutaneous Lymphoma International Consortium 'CLIC' study of prognostic parameters in advanced stages of mycosis fungoides and Sezary syndrome: Progress towards establishing a prognostic index to augment clinical staging
    Meeting Abstract

    Scarisbrick, J. J.; Quaglino, P.; Vermeer, M.; Whittaker, S.; Wood, G. S.; Duvic, M.; Prince, M.; Horwitz, S. M.; Hoppe, R. T.; Porcu, P.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Safe and effective treatment of patients with relapsed or refractory peripheral T-cell lymphoma (PTCL) and low baseline platelet counts with belinostat
    Meeting Abstract

    Savage, K. J.; Horwitz, S. M.; Zinzani, P. L.; Van Hoof, A.; Assouline, S. E.; Bhat, G.; Choi, M. R.; Allen, L. F.; Ben-Yehuda, D.; Jurczak, W.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • T cells in CTCL have an exhausted phenotype while cutaneous dendritic cells display a normally activated mature phenotype
    Meeting Abstract

    Querfeld, C.; Curran, S. A.; Leung, S.; Myskowski, P. L.; Horwitz, S. M.; Halpern, A. C.; Young, J. W.
    Blood (2014)

    Fulltext@MSK | Save
  • Romidepsin induces durable responses in patients with relapsed or refractory angioimmunoblastic T-cell lymphoma (AITL)
    Meeting Abstract

    Pro, B.; Horwitz, S. M.; Prince, H. M.; Foss, F. M.; Sokol, L.; Greenwood, M.; Caballero, D.; Morschhauser, F.; Wilhelm, M.; Pinter-Brown, L.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Clinical activity of duvelisib (IPI-145), a phosphoinositide-3-kinase-δ,γ inhibitor, in patients previously treated with ibrutinib
    Meeting Abstract

    Porcu, P.; Flinn, I.; Kahl, B. S.; Horwitz, S. M.; Oki, Y.; Byrd, J. C.; Sweeney, J.; Allen, K.; Faia, K.; Ni, M.; more...
    Blood (2014)

    Fulltext@MSK | Save
  • Patient characteristics and initial treatment patterns in the United States for the most common subtypes of peripheral T-cell lymphoma (PTCL)
    Meeting Abstract

    Pinter-Brown, L.; Foss, F. M.; Carson, K. R.; Horwitz, S. M.; Rosen, S. T.; Pro, B.; Federico, M.; Gisselbrecht, C.; Hsi, E. D.; Shustov, A. R.; more...
    Blood (2014)

    Fulltext@MSK | Save